|
US2519863A
(en)
|
1949-05-14 |
1950-08-22 |
Eastman Kodak Co |
Conversion of beta-, gamma-, and delta-tocopherol to alpha-tocopherol by aminoalkylation and reduction
|
|
US4977282A
(en)
|
1984-04-17 |
1990-12-11 |
Henkel Corporation |
Production of d-alpha-tocopherol from natural plant sources
|
|
EP0159018A3
(en)
*
|
1984-04-17 |
1986-10-01 |
HENKEL CORPORATION (a Delaware corp.) |
Production of d-alpha-tocopherol from natural plant sources
|
|
US4603142A
(en)
|
1984-06-01 |
1986-07-29 |
Wisconsin Alumni Research Foundation |
Cholesterol lowering method of use
|
|
JPS636186A
(ja)
|
1986-06-23 |
1988-01-12 |
タツタ電線株式会社 |
点滴監視装置
|
|
JPH0788376B2
(ja)
|
1986-09-02 |
1995-09-27 |
エーザイ株式会社 |
光学活性α−トコトリエノ−ルの製造方法
|
|
JP2685785B2
(ja)
|
1988-03-11 |
1997-12-03 |
エーザイ株式会社 |
光学活性α−トコトリエノールの製造方法
|
|
JPH029875A
(ja)
|
1988-03-16 |
1990-01-12 |
Bio Ind Kyokai |
トコフェロール及びトコトリエノールの製造方法
|
|
US5157132A
(en)
|
1990-05-18 |
1992-10-20 |
Carotech Associates |
Integrated process for recovery of carotenoids and tocotrienols from oil
|
|
CA2124086A1
(en)
|
1991-11-22 |
1993-05-27 |
Ronald H. Lane |
Tocotrienols and tocotrienol-like compounds and methods for their use
|
|
DE59605564D1
(de)
|
1995-03-28 |
2000-08-17 |
Hoffmann La Roche |
Aminomethylierung von Tocopherolen
|
|
US5660691A
(en)
|
1995-11-13 |
1997-08-26 |
Eastman Chemical Company |
Process for the production of tocotrienol/tocopherol blend concentrates
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
US5932748A
(en)
|
1997-06-06 |
1999-08-03 |
Roche Vitamins Inc. |
Process for permethylating non-α-tocopherols to produce α-tocopherol
|
|
SK283682B6
(sk)
*
|
1997-10-29 |
2003-11-04 |
Flexsys America L. P. |
Spôsob prípravy chinóndiimínu
|
|
JP2002501916A
(ja)
|
1998-01-29 |
2002-01-22 |
イーストマン ケミカル カンパニー |
トコール含有混合物からのトコトリエノールの分離方法及びその組成物
|
|
US6562372B1
(en)
|
1998-11-06 |
2003-05-13 |
Fuji Chemical Industry Co., Ltd. |
Tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
|
|
US6395915B1
(en)
|
1999-09-10 |
2002-05-28 |
Technikrom, Inc. |
Method for producing purified tocotrienols and tocopherols using liquid chromatography
|
|
MY127451A
(en)
|
1999-11-04 |
2006-12-29 |
Malaysian Palm Oil Board |
A method of chromatographic isolation for vitamin e isomers
|
|
DE10034233A1
(de)
*
|
2000-07-14 |
2002-01-24 |
Basf Ag |
Tocotrienolchinon-Cyclisierungsprodukte
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
US6838104B2
(en)
|
2000-12-20 |
2005-01-04 |
Archer Daniels Midland Company |
Process for the production of tocotrienols
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
JP4842455B2
(ja)
|
2001-06-13 |
2011-12-21 |
コマツＮｔｃ株式会社 |
半導体単結晶引上げ装置及びそのライン構成
|
|
JP2003171376A
(ja)
|
2001-09-27 |
2003-06-20 |
Lion Corp |
トコフェロール類及びトコトリエノール類濃縮物、その製造方法
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
US6590113B1
(en)
|
2002-03-26 |
2003-07-08 |
Ronald T. Sleeter |
Process for treating oils containing antioxidant compounds
|
|
WO2004042353A2
(en)
|
2002-10-30 |
2004-05-21 |
Galileo Pharmaceuticals, Inc. |
Identifying therapeutic compounds based on their physical-chemical properties
|
|
MY130618A
(en)
|
2002-11-27 |
2007-07-31 |
Malaysian Palm Oil Board |
A method of extracting and isolating minor components from vegetable oil
|
|
CA2580584C
(en)
|
2003-09-19 |
2015-07-28 |
Galileo Pharmaceuticals, Inc. |
Use of alpha-tocotrienol for treatment of mitochondrial diseases
|
|
WO2005035491A2
(en)
|
2003-10-10 |
2005-04-21 |
Yasoo Health, Inc. |
PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND
|
|
MY173044A
(en)
|
2003-11-19 |
2019-12-20 |
Carotech Bhd |
Recovery of phytonutriens from oils
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
CA2610152C
(en)
|
2005-06-01 |
2018-04-10 |
Edison Pharmaceuticals, Inc. |
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
ES2823728T3
(es)
|
2005-09-15 |
2021-05-10 |
Ptc Therapeutics Inc |
Variantes de cola de agentes terapéuticos con actividad redox para el tratamiento de enfermedades mitocondriales y otras afecciones y la modulación de biomarcadores de energía
|
|
EA019675B1
(ru)
|
2006-02-22 |
2014-05-30 |
Эдисон Фармасьютикалз, Инк. |
Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q
|
|
WO2007105297A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
メチン系色素とその用途
|
|
CN101610782A
(zh)
|
2007-01-10 |
2009-12-23 |
爱迪生药物公司 |
使用具有促红细胞生成素或血小板生成素活性的化合物治疗呼吸链紊乱
|
|
WO2008142433A1
(en)
|
2007-05-24 |
2008-11-27 |
Loders Croklaan B.V. |
Process for producing compositions comprising tocoherols and tocotrienols
|
|
EP3018122B1
(en)
|
2007-11-06 |
2018-10-10 |
BioElectron Technology Corporation |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
|
|
WO2009088572A2
(en)
|
2008-01-07 |
2009-07-16 |
Centocor, Inc. |
Method of treating erythropoietin hyporesponsive anemias
|
|
CA2708961C
(en)
|
2008-01-08 |
2017-03-28 |
Ptc Therapeutics, Inc. |
(het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
WO2009111543A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
Treatment of hearing and balance impairments with redox-active therapeutics
|
|
EP2310038A4
(en)
|
2008-05-15 |
2012-03-14 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCE OF IMPROVENCE WITH COMPOUNDS WITH ERYTHROPOETIN EFFECT
|
|
CA2724841A1
(en)
|
2008-05-22 |
2009-11-26 |
Edison Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
WO2009158348A1
(en)
|
2008-06-25 |
2009-12-30 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029706A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Parmaceuticals, Inc. a Delaware Corporation |
HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
BRPI0918139B1
(pt)
|
2008-09-10 |
2024-04-30 |
Ptc Therapeutics, Inc |
Composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos
|
|
CA2740773A1
(en)
|
2008-10-14 |
2010-04-22 |
Edison Pharmaceuticals, Inc. |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
CN102264730B
(zh)
*
|
2008-10-28 |
2016-04-13 |
爱迪生药物公司 |
用于生产生育三烯酚及衍生物的方法
|
|
JP2012525399A
(ja)
|
2009-04-28 |
2012-10-22 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
トコトリエノールキノンを用いる、レーバー遺伝性視神経症および優性遺伝性視神経萎縮症の治療
|
|
MX2011011310A
(es)
|
2009-04-28 |
2011-11-18 |
Edison Pharmaceuticals Inc |
Formulacion de tocotrienol quinonas para el tratamiento de enfermedades oftalmicas.
|
|
EP2424360A4
(en)
|
2009-04-28 |
2012-10-03 |
Ampere Life Sciences Inc |
TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES
|
|
EP2445519A4
(en)
|
2009-06-25 |
2012-12-26 |
Ampere Life Sciences Inc |
TREATMENT OF PERVASIVE DEVELOPMENT DISORDERS USING TOCOTRIENOLS OR TOCOTRIENOLS ENRICHED EXTRACTS
|
|
SI2470168T1
(en)
|
2009-08-26 |
2018-05-31 |
Bioelectron Technology Corporation |
Procedures for the prevention and treatment of brain ischemia
|
|
EP2519232A1
(en)
|
2009-12-31 |
2012-11-07 |
Edison Pharmaceuticals, Inc. |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
BR112012022634A2
(pt)
|
2010-03-09 |
2019-09-24 |
Edison Pharmaceuticals Inc |
síntese de derivados de alto-tocoferolquinona e métodos de utilização dos mesmos
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
JP2013523816A
(ja)
|
2010-04-06 |
2013-06-17 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
毛細血管拡張性運動失調症の治療
|
|
CN102985083A
(zh)
|
2010-04-27 |
2013-03-20 |
爱迪生药物公司 |
治疗眼科疾病的醌类的制剂
|
|
US20120101169A1
(en)
|
2010-07-14 |
2012-04-26 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
SG187744A1
(en)
|
2010-08-06 |
2013-03-28 |
Edison Pharmaceuticals Inc |
Treatment of mitochondrial diseases with naphthoquinones
|
|
WO2012068552A1
(en)
|
2010-11-19 |
2012-05-24 |
Edison Pharmaceuticals, Inc. |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
WO2012174286A1
(en)
|
2011-06-14 |
2012-12-20 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
WO2013006737A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc. |
Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
|
|
JP2014520894A
(ja)
|
2011-07-19 |
2014-08-25 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
|
|
CA2883879A1
(en)
|
2012-09-07 |
2014-03-13 |
Edison Pharmaceuticals, Inc. |
Quinone derivatives for use in the modulation of redox status of individuals
|
|
US8937191B2
(en)
|
2012-12-20 |
2015-01-20 |
Orochem Technologies, Inc. |
Recovery of highly pure alpha-tocotrienol from crude palm oil extract
|
|
US10470986B2
(en)
|
2013-03-08 |
2019-11-12 |
Conopco, Inc. |
Resorcinol compounds for dermatological use
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
CA2906145A1
(en)
|
2013-03-15 |
2014-09-18 |
Ptc Therapeutics, Inc. |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US9670170B2
(en)
|
2013-03-15 |
2017-06-06 |
Bioelectron Technology Corporation |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US20160115141A1
(en)
|
2013-05-31 |
2016-04-28 |
Edison Pharmaceuticals, Inc. |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|
|
WO2016100579A1
(en)
|
2014-12-16 |
2016-06-23 |
Edison Pharmaceuticals, Inc., |
Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
|
|
JP2018500317A
(ja)
|
2014-12-16 |
2018-01-11 |
バイオエレクトロン テクノロジー コーポレイション |
トロロックスのキラル分割のための方法
|
|
WO2016114860A1
(en)
|
2015-01-12 |
2016-07-21 |
Edison Pharmaceuticals, Inc. |
Quinones for protection against radiation exposure
|
|
WO2017106786A1
(en)
|
2015-12-16 |
2017-06-22 |
Bioelectron Technology Corporation |
Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
|
|
CN113024369A
(zh)
|
2015-12-17 |
2021-06-25 |
Ptc医疗公司 |
用于治疗氧化应急障碍的化合物
|
|
WO2017123820A1
(en)
|
2016-01-12 |
2017-07-20 |
Bioelectron Technology Corporation |
Methods for diagnosing and treating oxidative stress disorders using biomarkers
|
|
WO2017123823A1
(en)
|
2016-01-12 |
2017-07-20 |
Bioelectron Technology Corporation |
Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
|
|
US20190241497A1
(en)
|
2016-10-28 |
2019-08-08 |
Andrew W. Hinman |
Methods for analyzing p-hydroquinone levels and ratios
|
|
WO2018093957A1
(en)
|
2016-11-15 |
2018-05-24 |
Bioelectron Technology Corporation |
2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
|
|
WO2018129411A1
(en)
|
2017-01-06 |
2018-07-12 |
Bioelectron Technology Corporation |
Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
|
|
US20200121618A1
(en)
|
2017-04-14 |
2020-04-23 |
Bioelectron Technology Corporation |
Methods and compositions for treatment of inflammation and oxidative stress
|